Literature DB >> 27920178

Animal Models of Chikungunya Virus Infection and Disease.

Nicole N Haese1, Rebecca M Broeckel1, David W Hawman2, Mark T Heise3, Thomas E Morrison2, Daniel N Streblow1.   

Abstract

Chikungunya virus (CHIKV) is a reemerging alphavirus that causes acute febrile illness and severe joint pain in humans. Although acute symptoms often resolve within a few days, chronic joint and muscle pain can be long lasting. In the last decade, CHIKV has caused widespread outbreaks of unprecedented scale in the Americas, Asia, and the Indian Ocean island regions. Despite these outbreaks and the continued expansion of CHIKV into new areas, mechanisms of chikungunya pathogenesis and disease are not well understood. Experimental animal models are indispensable to the field of CHIKV research. The most commonly used experimental animal models of CHIKV infection are mice and nonhuman primates; each model has its advantages for studying different aspects of CHIKV disease. This review will provide an overview of animal models used to study CHIKV infection and disease and major advances in our understanding of chikungunya obtained from studies performed in these models.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Alphavirus; Chikungunya; animal models; mouse models; nonhuman primates

Mesh:

Year:  2016        PMID: 27920178      PMCID: PMC5137241          DOI: 10.1093/infdis/jiw284

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  52 in total

1.  Impaired quality of life after chikungunya virus infection: a 2-year follow-up study.

Authors:  Elisabeth Couturier; Francis Guillemin; Marie Mura; Lucie Léon; Jean-Marc Virion; Marie-José Letort; Henriette De Valk; Fabrice Simon; Véronique Vaillant
Journal:  Rheumatology (Oxford)       Date:  2012-03-16       Impact factor: 7.580

Review 2.  Chikungunya: Evolutionary history and recent epidemic spread.

Authors:  Scott C Weaver; Naomi L Forrester
Journal:  Antiviral Res       Date:  2015-05-12       Impact factor: 5.970

3.  Experimental infection of Macaca radiata with Chikungunya virus and transmission of virus by mosquitoes.

Authors:  S D Paul; K R Singh
Journal:  Indian J Med Res       Date:  1968-06       Impact factor: 2.375

4.  Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients.

Authors:  Gianandrea Borgherini; Patrice Poubeau; Frederik Staikowsky; Manuella Lory; Nathalie Le Moullec; Jean Philippe Becquart; Catherine Wengling; Alain Michault; Fabrice Paganin
Journal:  Clin Infect Dis       Date:  2007-04-18       Impact factor: 9.079

5.  Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.

Authors:  Pankaj Pal; Julie M Fox; David W Hawman; Yan-Jang S Huang; Ilhem Messaoudi; Craig Kreklywich; Michael Denton; Alfred W Legasse; Patricia P Smith; Syd Johnson; Michael K Axthelm; Dana L Vanlandingham; Daniel N Streblow; Stephen Higgs; Thomas E Morrison; Michael S Diamond
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

6.  Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response.

Authors:  David W Hawman; Kristina A Stoermer; Stephanie A Montgomery; Pankaj Pal; Lauren Oko; Michael S Diamond; Thomas E Morrison
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

7.  Chikungunya disease outbreak, Reunion Island.

Authors:  Loïc Josseran; Christophe Paquet; Abdelkrim Zehgnoun; Nadège Caillere; Alain Le Tertre; Jean-Louis Solet; Martine Ledrans
Journal:  Emerg Infect Dis       Date:  2006-12       Impact factor: 6.883

Review 8.  Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia.

Authors:  Laurence Dupuis-Maguiraga; Marion Noret; Sonia Brun; Roger Le Grand; Gabriel Gras; Pierre Roques
Journal:  PLoS Negl Trop Dis       Date:  2012-03-27

9.  Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period.

Authors:  Daouda Sissoko; Denis Malvy; Khaled Ezzedine; Philippe Renault; Frederic Moscetti; Martine Ledrans; Vincent Pierre
Journal:  PLoS Negl Trop Dis       Date:  2009-03-10

10.  Human muscle satellite cells as targets of Chikungunya virus infection.

Authors:  Simona Ozden; Michel Huerre; Jean-Pierre Riviere; Lark L Coffey; Philippe V Afonso; Vincent Mouly; Jean de Monredon; Jean-Christophe Roger; Mohamed El Amrani; Jean-Luc Yvin; Marie-Christine Jaffar; Marie-Pascale Frenkiel; Marion Sourisseau; Olivier Schwartz; Gillian Butler-Browne; Philippe Desprès; Antoine Gessain; Pierre-Emmanuel Ceccaldi
Journal:  PLoS One       Date:  2007-06-13       Impact factor: 3.240

View more
  23 in total

1.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

2.  N-Linked Glycans Shape Skin Immune Responses during Arthritis and Myositis after Intradermal Infection with Ross River Virus.

Authors:  Kothila Tharmarajah; Arun Everest-Dass; Jelena Vider; Xiang Liu; Joseph R Freitas; Helen Mostafavi; Jayaram Bettadapura; Mark von Itzstein; Nicholas P West; Adam Taylor; Suresh Mahalingam; Ali Zaid
Journal:  J Virol       Date:  2022-08-24       Impact factor: 6.549

Review 3.  Understanding Molecular Pathogenesis with Chikungunya Virus Research Tools.

Authors:  Guillaume Carissimo; Lisa F P Ng
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.291

4.  Live-attenuated RNA hybrid vaccine technology provides single-dose protection against Chikungunya virus.

Authors:  Emily A Voigt; Jasmine Fuerte-Stone; Brian Granger; Jacob Archer; Neal Van Hoeven
Journal:  Mol Ther       Date:  2021-05-29       Impact factor: 12.910

5.  Chikungunya virus as a trigger for different renal disorders: an exploratory study.

Authors:  Denise Maria do Nascimento Costa; Carlos Eduardo Machado; Precil Diego Neves; Dyego José Brito; Samira Oi; Flávio Henrique Barros; Luiz Tadeu Figueiredo; Stanley Almeida Araujo; Francisco Ladchumananandasivam; Marlene Antônia Dos Reis; Weverton Luchi; Joyce Lages; Natalino Salgado Filho; Luiz Fernando Onuchic; Angela Luzia Duarte; Claudia Diniz Lopes Marques; Maria Rosângela Cunha Duarte Coêlho; Camila Oliveira; Gisele Vajgel; Maria Alina Cavalcante; Lucila Valente; Vera Magalhães; Gyl Eanes Barros Silva
Journal:  J Nephrol       Date:  2022-02-04       Impact factor: 4.393

6.  Lower temperatures reduce type I interferon activity and promote alphaviral arthritis.

Authors:  Natalie A Prow; Bing Tang; Joy Gardner; Thuy T Le; Adam Taylor; Yee S Poo; Eri Nakayama; Thiago D C Hirata; Helder I Nakaya; Andrii Slonchak; Pamela Mukhopadhyay; Suresh Mahalingam; Wayne A Schroder; William Klimstra; Andreas Suhrbier
Journal:  PLoS Pathog       Date:  2017-12-27       Impact factor: 6.823

7.  Complete Genome Sequences of 15 Chikungunya Virus Isolates from Puerto Rico.

Authors:  Wes A Sanders; Kristin Long; Brenda Rivera; Heather A Vincent; Mark T Heise; Jose F Rodriguez-Orengo; Nathaniel J Moorman
Journal:  Genome Announc       Date:  2017-07-06

Review 8.  Chikungunya Virus Vaccines: Platforms, Progress, and Challenges.

Authors:  Victor R DeFilippis
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.291

Review 9.  Chikungunya Virus: Pathophysiology, Mechanism, and Modeling.

Authors:  Vaishnavi K Ganesan; Bin Duan; St Patrick Reid
Journal:  Viruses       Date:  2017-12-01       Impact factor: 5.048

10.  Chikungunya virus infection in Cynomolgus macaques following Intradermal and aerosol exposure.

Authors:  Chris M Cirimotich; Eric M Vela; Jennifer Garver; Roy E Barnewall; Brian D Miller; Gabriel T Meister; James V Rogers
Journal:  Virol J       Date:  2017-07-20       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.